Anti-Senescence Therapy Market
Anti-Senescence Therapy Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Anti-Senescence Therapy Market Size and Growth
The Anti-Senescence Therapy market is rapidly expanding, driven by rising aging populations and increasing demand for effective age-related treatments. As of 2023, the market is valued at approximately $8 billion, with projections indicating significant growth over the next decade, reflecting innovation and investment in regenerative medicine technologies.
Companies Covered
(Covid 19 Impact Covered)
◍ Unity Biotechnology
◍ Siwa Therapeutics
◍ Calico LLC
◍ AgeX Therapeutics ， Inc
◍ Numeric Biotech
◍ Human Longevity, Inc. (HLI)
◍ Cleara Biotech
◍ OisinBiotechnologies
◍ Recursion Pharmaceuticals
◍ Sierra Sciences
◍ Proteostasis Therapeutics
◍ Senolytic Therapeutics
◍ Allergan
The Anti-Senescence Therapy Market features companies like Unity Biotechnology focusing on senolytics, Siwa Therapeutics on targeted therapies, and Calico LLC with a broad aging strategy. Collaboration and innovation drive market growth, with Unity's revenue exceeding $20 million and Calico at approximately $600 million, enhancing the overall sector. Request Sample Report
Market Segmentation
By Application
Cardiovascular Diseases
Neural Degenerative Diseases
Ophthalmology Disorders
Others
Request Sample Report
By Product
Gene Therapy
Immunotherapy
Others
Market Growth
Request Sample Report
$ X Billion USD
